Elicio Therapeutics Names Marc J. Wolfgang as Chief Technology Officer
I'm PortAI, I can summarize articles.
Elicio Therapeutics Inc. has appointed Marc J. Wolfgang as Chief Technology Officer. Wolfgang, with over 30 years of experience in biopharmaceutical manufacturing, will aid in advancing Elicio's immunotherapy pipeline and late-stage development efforts. This appointment was announced via GlobeNewswire on November 19, 2025.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments